NXGN - クオリティ・システムズ （NextGen Healthcare Inc.）

ATLANTA--(BUSINESS WIRE)--NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of innovative, cloud-based healthcare technology solutions, today announced its operating results for the fiscal fourth quarter and year ended March 31, 2022. Fiscal 2022 Fourth Quarter and Full Year Highlights Total revenue for the fiscal 2022 fourth quarter was $151.3 million compared to $144.2 million for the same period a year ago, or 5% growth. Revenue for the fiscal year ended March 31, 2022 was $596.4 m

NextGen Healthcare (NXGN) is scheduled to announce Q4 earnings results on Tuesday, May 17th, after market close.The consensus EPS Estimate is $0.19 (-9.5% Y/Y) and the consensus…

Upgrades For Coupang Inc (NYSE: CPNG ), JP Morgan upgraded the previous rating of Neutral to Overweight. The stock has a 52-week-high of $46.00 and a 52-week-low of $11.91. At the end of the last trading period, Coupang closed at $11.99. According to Guggenheim, the prior rating for NextGen Healthcare Inc (NASDAQ: NXGN ) was changed from Neutral to Buy. In the third quarter, NextGen Healthcare showed an EPS of $0.24, compared to $0.26 from the year-ago quarter. The stock has a 52-week-high of $21.87 and a 52-week-low of $13.64. At the end of the last trading period, NextGen Healthcare closed at $19.52. According to CLSA, the prior rating for Melco Resorts and Entertainment Ltd (NASDAQ: MLCO ) was changed from Outperform to Buy. For the first quarter, Melco Resorts and Enter had an EPS of $0.37, compared to year-ago quarter EPS of $0.44. The stock has a 52-week-high of $19.18 and a 52-week-low of $5.12. At the end of the last trading period, Melco Resorts and Enter closed at $5.19. Raymond James upgraded the previous rating for Jounce Therapeutics Inc (NASDAQ: JNCE ) from Outperform to Strong Buy.

ATLANTA--(BUSINESS WIRE)---- $NXGN #NextGenHealthcare--NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of innovative, cloud-based healthcare technology solutions, today announced a partnership with Circuit Clinical to bring clinical trial access to patients of Federally Qualified Health Centers (FQHCs) through over 14,000 providers that utilize NextGen Healthcare solutions. Historically, these underserved communities have not had easy access to participate in transformative clinical research that can provide en

ATLANTA--(BUSINESS WIRE)---- $NXGN #NextGenHealthcare--NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of innovative, cloud-based healthcare technology solutions, today announced a partnership with Circuit Clinical to bring clinical trial access to patients of Federally Qualified Health Centers (FQHCs) through over 14,000 providers that utilize NextGen Healthcare solutions. Historically, these underserved communities have not had easy access to participate in transformative clinical research that can provide en

ATLANTA--(BUSINESS WIRE)--NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of innovative, cloud-based healthcare technology solutions, today announced preliminary unaudited fiscal 2022 fourth quarter and year ended March 31, 2022 results and introduced financial guidance for fiscal 2023 as summarized below. The company will discuss its preliminary results and growth strategy at its Investor Event, which is scheduled for Tuesday, May 3, 2022 at 10 a.m. EST. See below for more informat

ATLANTA--(BUSINESS WIRE)--NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of innovative, cloud-based healthcare technology solutions, today announced it will release its fiscal 2022 fourth quarter and full-year ended March 31, 2022 operating results on Tuesday, May 17, 2022 after market close, with a conference call to follow at 5:00 p.m. Eastern Time. Shareholders and interested participants may listen to a live broadcast of the conference call by dialing 866-831-8713 or 203-518-98

Provider of ambulatory-focused technology solutions, NextGen Healthcare Inc (NASDAQ: NXGN ) posted Q3 FY22 sales of $149.7 million , +6% Y/Y, beating the consensus of $146.32 million. Recurring revenue accounted for 90% of total revenue, or $134.5 million, growing 5% Y/Y. In Q3, subscription services revenue generated $41.2 million, up 8% Y/Y, driven by demand Full story available on Benzinga.com

Provider of ambulatory-focused technology solutions, NextGen Healthcare Inc (NASDAQ: NXGN ) posted Q3 FY22 sales of $149.7 million , +6% Y/Y, beating the consensus of $146.32 million. Recurring revenue accounted for 90% of total revenue, or $134.5 million, growing 5% Y/Y. In Q3, subscription services revenue generated $41.2 million, up 8% Y/Y, driven by demand Full story available on Benzinga.com

Related Stocks: NXGN ,

This move is a reversal from the day prior, which saw price move up. The post Nextgen Healthcare Inc (NXGN): Price Now Near $16.83; Daily Chart Shows An Uptrend on 50 Day Basis appeared first on ETF Daily News .